Scientific Program – GYNECOLOGYFriday, November 28 & Saturday, November 29, 2025 |
![]() |
Friday, November 28
08:30-09:00 | GOOD MORNING ROME PLENARY LECTURE | Live streamed from HALL A |
Capsule | A decade ago, a pionering procedure was successfully launched | |
Chairpersons | Zion Ben Rafael, Israel Rene Frydman, France |
|
08:30-08:55 | Pioneering uterus transplantation: Reflections on breakthroughs and deliveries Mats Brännström, Sweden |
|
08:55-19:00 | Discussion |
09:00-10:00 | THE GUT, VAGINAL AND BLADDER MICROBIOME IN WOMEN’S LIFESPAN | HALL C |
Capsule | Microbiome, so much information, yet so little clinical conclusion | |
Chairpersons | Andrea Genezzani, Italy Mark Brincat, Malta |
|
09:00-09:15 |
The gut microbiome. The great director of women’s health |
|
09:15-09:20 |
Discussion |
|
09:20-09:35 |
The vaginal and bladder microbiome: The secret dialogue, in the lifespan |
|
09:35-09:40 |
Discussion |
|
09:40-09:55 |
The uterine microbiome as a marker of female infertility |
|
09:55-10:00 |
Discussion |
10:00-10:30 | Coffee break, visit the exhibition, and e-poster viewing |
10:30-12:00 | NOVEL GLOBAL GUIDANCE ON POI: TOWARDS PERSONALIZED MEDICINE | HALL C |
Capsule | ||
Chairpersons | Nick Panay, UK Micheline Misrahi, France |
|
10:30-10:55 |
Genetics of POI: a leap for diagnosis and personalized medicine in novel 2024 guidelines |
|
10:55-11:15 |
Autoimmunity in POI |
|
11:15-11:40 |
Short and long term cardiometabolic risks of POI |
|
11:40-12:00 |
Update of POI guidelines (from ESHRE and our latest searches of literature for IMS POI recommendations) |
12:00-12:05 | Short break |
12:05-13:05 | INDUSTRY SUPPORTED SESSION | HALL A and B |
13:05-14:00 | Lunch break, visit the exhibition, e-poster viewing, and moderated e-poster sessions |
14:00-15:00 | INDUSTRY SUPPORTED SESSION | HALL A and B |
15:00-15:05 | Short break |
15:05-16:35 | TBA | HALL C |
Capsule | ||
Chairpersons | Andrea Genazzani, Italy Alessandra Graziottin, Italy |
|
15:05-15:35
15:05 |
Debate: Patients with early menopause should be treated continuously to prevent chronic diseases For: Nick Panay, UK |
|
15:35-16:05
15:35 |
Debate: Menopause symptoms and diseases can be managed without Menopausal HT? For: Santiago Palacios, Spain |
|
16:05-16:35
16:05 |
Debate: Lichen Sclerosus or Vulvodynia Lichen Sclerosis: Zdenko Vizintin, Slovenia |
16:35-17:00 | Coffee break, visit the exhibition, and e-poster viewing |
17:00-18:30 | MENOPAUSE: BEYOND THE MINIMISATION OF HOT FLUSHES | HALL C |
Capsule | ||
Chairpersons |
Rossella Nappi, Italy |
|
17:00-17:15 |
Have we gone a full circle and should offer HT for all? |
|
17:15-17:20 |
Discussion |
|
17:20-17:40 |
Predicting, preventing and optimising cardiometabolic menopause outcomes in “at risk” women |
|
17:40-17:45 |
Discussion |
|
17:45-18:00 |
The bladder after the menopause: A call for action |
|
18:00-18:05 |
Discussion |
|
18:05-18:25 |
Osteoarthritis: Why estrogens have a specific role |
|
18:25-18:30 |
Discussion |
Saturday, November 29
08:30-10:00 | GOOD MORNING ROME PLENARY LECTURE | Live streamed from HALL A |
Capsule | ||
Chairpersons |
Bart Fauser, Netherlands |
|
08:30-08:55 |
Endometriosis before and during pregnancy |
|
08:55-09:00 | Discussion |
09:00-10:30 | SLS – SOCIETY OF LAPAROSCOPIC & ROBOTIC SURGEONS | HALL C |
Capsule | ||
Chairpersons | Jessica Ybanez Morano, USA | |
10:30-11:00 | Coffee break, visit the exhibition, and e-poster viewing |
11:00-12:30 | FERTILITY PRESERVATION | HALL C |
Capsule | ||
Chairpersons | ||
11:00-11:15 | Fertility – sparing management in recurrent gynecological cancer | |
11:15-11:20 | Discussion | |
11:20-11:35 | Fertility preservation in borderline and malignant tumors | |
11:35-11:40 | Discussion | |
11:40-12:10
11:40 |
Debate: Is there room for ovarian tissue cryopreservation for breast cancer patients? What is the risk?
No: |
|
12:10-12:25 | What are the differences between fertility preservation for benign diseases and malignancy? | |
12:25-12:30 | Discussion |
12:30-13:30 | Lunch break, visit the exhibition, and e-poster viewing |
13:30-15:00 | PCOS | HALL C |
Capsule | ||
Chairpersons |
Bart Fauser, Netherlands |
|
13:30-14:00
13:30 |
Debate: PCOS (new section) Is the diagnostic criteria for PCOS adequate for effective management? Yes: TBA |
|
13:50-14:05 |
SEMaglutides (GLP1 antagonist) and PCO |
|
14:05-14:10 | Discussion | |
14:10-14:25 |
Challenges in diagnosing PCOS in adolescents |
|
14:25-14:30 |
Discussion |
15:00-16:30 | TBA | HALL C |
Capsule | ||
Chairpersons |
|
|
15:00-15:15 |
There is a need for androgen therapy after menopause |
|
15:15-15:20 |
Discussion |
|
15:20-15:40 | Neurokinin-3 receptor antagonists: A novel approach to treating menopausal vasomotor symptoms Santiago Palacios, Spain |
|
15:40-15:45 |
Discussion |
|
15:45-16:05 |
Sexual arousal: The winning strategy |
|
16:05-16:10 |
Discussion |
|
16:10-16:25 |
Managing sexuality issues in patients contraindicated to or unresponsive to estrogens and androgens |
|
16:25-16:30 |
Discussion |